Ontology highlight
ABSTRACT: Purpose
The pharmacokinetic properties of plasma NO3- and its reduced metabolite, NO2-, have been separately described, but there has been no reported attempt to simultaneously model their pharmacokinetics following NO3- ingestion. This report describes development of such a model from retrospective analyses of concentrations largely obtained from primary endpoint efficacy trials.Methods
Linear and non-linear mixed effects analyses were used to statistically define concentration dependency on time, dose, as well as patient and study variables, and to integrate NO3- and NO2- concentrations from studies conducted at different times, locations, patient groups, and seve
SUBMITTER: Coggan AR
PROVIDER: S-EPMC7719268 | biostudies-literature | 2020 Nov
REPOSITORIES: biostudies-literature